好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Use of Quantile Regression to Characterize Solanezumab Effects across Percentiles of Disease Progression in EXPEDITION Alzheimer's Disease Trials
Aging, Dementia, and Behavioral Neurology
(-)
102
Authors/Disclosures
Yun-Fei Chen, PhD
PRESENTER 		No disclosure on file
No disclosure on file
Karen Sundell (Eli Lilly and Company) Karen Sundell has received personal compensation for serving as an employee of Acumen Pharmaceuticals . Karen Sundell has stock in Acumen Pharmaceuticals .
Karla Alaka No disclosure on file
Kory Schuh Kory Schuh has received personal compensation for serving as an employee of Eli Lilly and Company.
Joel Raskin No disclosure on file
Robert A. Dean Robert A. Dean has received personal compensation for serving as an employee of Acumen Pharmaceutics. Robert A. Dean has received personal compensation for serving as an employee of Gates Ventures. Robert A. Dean has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Robert A Dean Consulting, LLC. Robert A. Dean has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen.